Helix Holdings II LLC
SEC CIK 1869101 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BBOT | BridgeBio Oncology Therapeutics, Inc. | Dir, 10% | 509.0K | — | — | 1 | 2024-02-13 | 2024-02-13 |
Most active insiders at BBOT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Elmelech Idan | COO, Principal Financial Ofcr | — | — |
| 2 | Beltran Pedro | Pres, CEO, Dir | — | — |
| 3 | Ben Yong | Chief Med, Dev Off | — | — |
| 4 | Mehra Uneek | Former Off | — | — |
| 5 | Cobo Marc | Principal Accounting Off | — | — |
| 6 | BridgeBio Pharma, Inc. | 10% | — | — |
| 7 | Chen Bihua | Dir, 10% | — | — |
Helix Holdings II LLC made no open-market trades at BBOT in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-02-13 | 2024-02-13 | BBOT | BridgeBio Oncology Therapeutics, Inc. | Helix Holdings II LLC | Dir, 10% | A - Grant | $10.00 | +509.0K | 509.0K | New | +$5.09M |
Purchase Sale Sale after option exercise All abbreviations